Fresenius Medical Care AG & Co. KGaA (FME) Given a €78.00 Price Target at Cfra

Cfra set a €78.00 ($90.70) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report sent to investors on Wednesday morning. The brokerage currently has a neutral rating on the stock.

Several other equities analysts also recently commented on FME. UBS Group set a €87.00 ($101.16) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Tuesday, June 26th. Morgan Stanley set a €93.00 ($108.14) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Tuesday, July 3rd. Credit Suisse Group set a €91.00 ($105.81) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Wednesday, July 4th. Nord/LB set a €102.00 ($118.60) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Friday, July 6th. Finally, Bank of America set a €102.00 ($118.60) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Tuesday, July 10th. Nine equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Fresenius Medical Care AG & Co. KGaA currently has an average rating of Buy and an average target price of €92.77 ($107.87).

FME stock opened at €70.10 ($81.51) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a one year low of €75.53 ($87.83) and a one year high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Recommended Story: Book Value Per Share – BVPS

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply